Platform Therapeutic Education in Heart Failure and Coronary Disease
METISCARDIO
Telephonic Platform of Follow up, Therapeutical Education and Coordination in Secondary Prevention in Patients With Heart Failure and Coronary Disease
1 other identifier
interventional
555
1 country
4
Brief Summary
A first therapeutic education is given before patient's discharge at the hospital, then a dedicated nurse follows patients through the phone,regularly according to patients' needs, continues to give advise on risk factors, information on medication and alert symptoms and therapeutic education.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable heart-failure
Started May 2010
Longer than P75 for not_applicable heart-failure
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2010
CompletedFirst Submitted
Initial submission to the registry
May 23, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2013
CompletedFirst Posted
Study publicly available on registry
June 5, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2014
CompletedMay 5, 2015
May 1, 2015
3.1 years
May 23, 2013
May 4, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
number of patient with a better of quality of life
quality of life is evaluated with appropriate questionnaires
1 year
Secondary Outcomes (2)
number of patients who improve their knowledge of disease
1 year
number of hospitalizations during the follow up
1 year
Study Arms (3)
therapeutic education class 1
OTHERpatients in class 1 will have a follow up call with therapeutic education every 3 months. this is the light follow up.
therapeutic education class 2
OTHERpatients in class 2 will have a follow up call with therapeutic education every month. this is the moderate follow up
therapeutic education class 3
OTHERpatients in class 3 will have a follow up call with therapeutic education twice a month. this is the heavy follow up.
Interventions
knowledge of disease, risk factors, diet, medication, alert symptoms
Eligibility Criteria
You may qualify if:
- hospitalization for acute coronary syndrome (ST-segment elevation myocardial infarction ,no ST-segment elevation myocardial infarction ST , unstable angina)
- hospitalization for heart failure
- acute coronary syndrome \< 3 months
- heart failure \< 3 months
- coronary by-pass surgery \< 3 months
You may not qualify if:
- complicated acute coronary syndrome (ventricular arrhythmia, heart failure, mechanical complications, cardiogenic shock)
- valvular cardiac pathology
- obstructive cardiomyopathy
- planned cardiac transplantation
- severe neurological or psychiatric troubles
- loss of autonomy
- other (refusal, language, nursing house, way of life not compatible with follow up, refusal of telephonic contacts)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Institut Coeur Effort Sante
Paris, 75005, France
Clinique Turin
Paris, 75008, France
Hopital Saint Antoine
Paris, 75012, France
Centre Cardiologique Alfred Kastler
Sarcelles, 95200, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
ariel a cohen, md
Resicard
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- head of the departement of cardiology,Saint Antoine hospital , Paris
Study Record Dates
First Submitted
May 23, 2013
First Posted
June 5, 2013
Study Start
May 1, 2010
Primary Completion
June 1, 2013
Study Completion
June 1, 2014
Last Updated
May 5, 2015
Record last verified: 2015-05